CN106983778A - A kind of Moringa hypoglycemic activity composition and its application - Google Patents

A kind of Moringa hypoglycemic activity composition and its application Download PDF

Info

Publication number
CN106983778A
CN106983778A CN201710344870.4A CN201710344870A CN106983778A CN 106983778 A CN106983778 A CN 106983778A CN 201710344870 A CN201710344870 A CN 201710344870A CN 106983778 A CN106983778 A CN 106983778A
Authority
CN
China
Prior art keywords
moringa
leaf
total
hypoglycemic activity
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710344870.4A
Other languages
Chinese (zh)
Inventor
赵鹤
赵一鹤
施蕊
张静美
夏菁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yunnan Academy of Forestry
Original Assignee
Yunnan Academy of Forestry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yunnan Academy of Forestry filed Critical Yunnan Academy of Forestry
Priority to CN201710344870.4A priority Critical patent/CN106983778A/en
Publication of CN106983778A publication Critical patent/CN106983778A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488Pueraria (kudzu)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/894Dioscoreaceae (Yam family)
    • A61K36/8945Dioscorea, e.g. yam, Chinese yam or water yam
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/53Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/55Liquid-liquid separation; Phase separation

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to the component composition of a kind of Moringa hypoglycemic activity composition and its application, including following masses part:0~10 part of leaf of Moringa total saposins, 0~20 part of total flavones of Moringa oleifera leaf, 0~5 part of leaf of Moringa total alkaloid, 20~65 parts of auxiliary material, are zero when wherein leaf of Moringa total saposins, total flavones of Moringa oleifera leaf are different with leaf of Moringa total alkaloid.The present invention raw material both from Moringa in itself, pass through Phytochemistry extraction separation method, blood sugar reducing component therein is subjected to separating-purifying respectively, obtain leaf of Moringa total saposins, total flavones of Moringa oleifera leaf and leaf of Moringa total alkaloid, the Traditional Chinese medicine for reducing blood glucose of compatibility integration of drinking and medicinal herbs prepares Moringa blood sugar reducing food, health products etc. jointly again, and active constituent concentration is high, blood sugar decreasing effect is obvious, without any toxicity and side effects, it can be eaten for a long time, it is hypoglycemic while can also nutrition and health care.

Description

A kind of Moringa hypoglycemic activity composition and its application
Technical field
The present invention relates to a kind of Moringa hypoglycemic activity composition and its application, category natural product extraction application technology neck Domain.
Background technology
Moringa (Moringa oleifera) belong to Moringaceae (Moringaceae) Moringa (Moringa Adans.) Torrid zone fallen leaves woody vegetables and oilseed plant, Moringa blade and Fruit pod are rich in several mineral materials, vitamin, protein and amino acid Etc. active ingredient, and fat content is relatively low, its active component have anti-oxidant and protection liver, hypoglycemic, reducing blood lipid and blood pressure, The health-care efficacies such as anti-inflammation.
Moringa complete stool edible, containing abundant protein, lipid, carbohydrate and vitamin etc., in many developing countries It is used as the dietary supplements generally used.In the west African state, Moringa is otherwise known as miracle tree(miracle tree), church of the world Servers Organization is just directed to promoting the cultivation of Moringa and edible process technology, recommends everyone daily edible soupspoon of local resident peppery Wooden leaf powder, to substitute the import medicine of costliness, improves resident's physical function, treatment malnutrition or the disease being induced by it. UCLA nutritionist points out, daily a soupspoon(About 15g)Leaf of Moringa powder, you can meet a children tieed up needed for one day The intake of raw element and essential amino acid.According to Liu Changfen etc. research, it is known that the leaf of Moringa nutritional ingredient of Different Provenances is Difference, but rich in nutrition content, content are balanced.There is research to point out that Moringa leaf protein and total dietary fiber are higher simultaneously, Fat content is low, and vitamin, the digestibility of Grapeseed Oil, absorptivity are all higher than other plant foods[50].Moringa Seed contains abundant fat, protein and liposoluble vitamin, can be processed as oil ben and high protein feed best in quality. Dong little Ying points out that the protein in Moringa benevolence is 4 times of milk, and benevolence contains 17 kinds of amino acid, and 8 kinds of human bodies must ammonia Base acid content is also enriched very much.
Also containing feature organic molecules such as abundant saponins compound, flavones, organic sulfur compounds in the leaf of Moringa, Though human body is smaller to the demand of these materials, plays raising Abwehrkraft des Koepers, remove the effect such as free radical and anticancer, mesh It is preceding it is not yet found that to the report of Moringa these feature organic molecules further investigation.There is research to point out, also contain in leaf of Moringa There are the saponin(e and aldehydes matter of some anti-nutrition components, but saponin(e is inert, and phenols dosage also far smaller than causes in animal The degree of restriction of poison.Also alkaloid component is contained in Moringa benevolence, but these compositions only just produce cardiac stimulant in heavy dose intake And the effect of rise blood pressure.Because these anti-nutrition component contents are few or it is unobvious to act on, hold again in general process It is easily destroyed, therefore toxic side effect will not be produced to human body.
Diabetes (Diabetes Mellitus, DM) are a classes due to insulin secretion definitely or relative deficiency, glycometabolism Endocrine metabolism disease caused by disorder by principal character of hyperglycaemia.Whole world diabetic's number drastically rises at present Height, prevention and treatment diabetes and its complication are very urgent.With the further investigation to pathogenesis of diabetes mellitus, according to hair Sick key target spot mechanism of action, which finds effective hypoglycemic medicine, turns into new focus.
Ndong etc., as animal model, glucose tolerance is carried out to rat using non-obese type diabetes B (GK) rat Experiment, oral Gavage glucose dose is in terms of 29/kg, and leaf of Moringa pulvis amount is based on 200mg/kg, and detection mouse feeding is preceding and raises 2h change of blood sugar, as a result finds that the fasting blood glucose level and level of postprandial blood sugar that do not feed the GK rats of leaf of Moringa powder are high after feeding In control rats, show that feeding leaf of Moringa powder can improve the glucose tolerance of diabetic mice.
Studied and found by the hypoglycemic animal experiment of total flavones of Moringa oleifera leaf (TFM), TFM can significantly reduce alloxan The blood glucose of diabetic mice, while SOD in serum vigor can be improved, reduces Content of MDA, and TFM is to normal mouse Blood sugar level without influence.
The Moringa root extract that Gupta etc. gives respectively to diabetes rat, as a result shows, moringa root can be reduced in serum Glucose and content of nitric oxide, increase serum insulin and protein level;Pancreatic tissue antioxidant levels can be increased, reduced The content of Thiobarbituric Acid Reactive Substance, with obvious hypoglycemic and antioxidation activity.
The content of the invention
In order to solve the deficiencies in the prior art, there is provided a kind of Moringa hypoglycemic activity by primary raw material of Moringa by the present invention Composition and its application, then compatibility other Traditional Chinese medicine for reducing blood glucose powder prepare the hypoglycemic pressed candy of Moringa, oral effervescent tablet, piece The formulations such as agent, capsule, and applied in functional food and diabetic's nutritional supplement arts.
The technical solution adopted by the present invention is as follows:A kind of Moringa hypoglycemic activity composition, includes the group of following masses part It is grouped into:
0~10 part of leaf of Moringa total saposins, 0~20 part of total flavones of Moringa oleifera leaf, 0~5 part of leaf of Moringa total alkaloid, auxiliary material 20~65 Part, it is zero when wherein leaf of Moringa total saposins, total flavones of Moringa oleifera leaf are different with leaf of Moringa total alkaloid.
The auxiliary material is cornstarch, microcrystalline cellulose, D-sorbite, fruit powder, mannitol, maltodextrin, lactose, sugarcane One or more in sugar, vitamin C, sodium acid carbonate, citric acid, calcium carbonate.
The Moringa hypoglycemic activity composition also includes kudzu-vine root powder and/or yam flour, and kudzu-vine root powder and yam flour are ultra micro Powder.
The leaf of Moringa total saposins are made through following operation:By leaf of Moringa that is fresh or drying, pass through 20 mesh medicines after pulverizing Sieve, addition 1 is calculated as by solid-to-liquid ratio g/mL:5~10, deionized water is added, is decocted 2~3 times, 2~3h every time, merging filtrate concentration To the concentrated solution that relative density is 0.9~1.2mg/mL, 95% ethanol is added, repeatedly to add on a small quantity, does not stop stirring, directly To flocky precipitate is obtained, stirring without precipitation untill continuing to separate out;12~24h is placed in 4~6 DEG C of refrigerators, suction filtration, filtrate subtracts Pressure concentration, 40~50 DEG C of thickening temperature volatilizes and leaf of Moringa total saposins is obtained after solvent.
The total flavones of Moringa oleifera leaf is made through following operation:Dry leaf of Moringa is crushed, sieved by 20 mesh medicines, by liquid material Volume ratio 5~10:1, add concentration and soaked for 40~60v/v% ethanol after 20~30min, refluxing extraction 2~3 times, every time 2 ~3h, merging filtrate is concentrated under reduced pressure, 50~60 DEG C of thickening temperature, is concentrated into medicinal extract completely without ethanol flavor, obtains leaf of Moringa total Extract;Leaf of Moringa total extract is passed through into polycaprolactam resin, with distillation 8~10 retention volumes of water elution, to wash-off Liquid is clarified, and is changed 4~5 retention volumes of ethanol elution that concentration is 70 v/v %, flow velocity is 3mL/ming, is collected eluent, Ethanol is reclaimed, total flavones of Moringa oleifera leaf is obtained.
The leaf of Moringa total alkaloid is made through following operation:Dry moringa root is crushed, sieved by 20 mesh medicines, by liquid Expect volume ratio 5~10:1, it is that 1~5wt% aqueous sulfuric acids are decocted 2~3 times with concentration, each 2h, merging filtrate, then use concentration PH is adjusted to neutrality for 1~5wt% calcium hydroxide, is then extracted, extracted 3~5 times repeatedly with dichloromethane, reclaims two Chloromethanes, obtains leaf of Moringa total alkaloid.
The Moringa hypoglycemic activity composition is in the formulations such as pressed candy, oral effervescent tablet, lozenge, capsule are prepared Application.
Advantage and effect that the present invention possesses:The raw material of the present invention in itself, is extracted both from Moringa by Phytochemistry Separation method, separating-purifying is carried out by blood sugar reducing component therein respectively, obtains leaf of Moringa total saposins, total flavones of Moringa oleifera leaf and peppery Wooden leaf total alkaloid, then Traditional Chinese medicine for reducing blood glucose Chinese yam, the root of kudzu vine etc. of compatibility integration of drinking and medicinal herbs prepare Moringa blood sugar reducing food, health care jointly Product etc., active constituent concentration is high, blood sugar decreasing effect is obvious, in the integration of drinking and medicinal herbs catalogue that planning commission's announcement is all defended using country Plant be raw material, without any toxicity and side effects, can be eaten for a long time, it is hypoglycemic and meanwhile can also nutrition and health care, wherein Chinese yam is hypoglycemic same When also there is filling liver kidney, invigorating the spleen gas, root of kudzu vine relieving superficies by cooling Shengyang Zhixie can expand blood vessel, hypotensive is hypoglycemic.
Embodiment
Below by embodiment, the present invention will be further described.
Embodiment 1
Pressed candy is made up of the component of following masses part:
10 parts of total flavones of Moringa oleifera leaf, 5 parts of lactose, 60 parts of maltodextrin, 10 parts of kudzu-vine root powder, 10 parts of yam flour.
Said components are mixed, direct powder compression, prepare leaf of Moringa pressed candy.
The total flavones of Moringa oleifera leaf is made through following operation:Dry leaf of Moringa is crushed, sieved by 20 mesh medicines, by liquid material Volume ratio 8:1, after adding concentration for 50v/v% ethanol immersion 25min, refluxing extraction 2 times, each 3h, merging filtrate, decompression Concentration, 55 DEG C of thickening temperature is concentrated into medicinal extract completely without ethanol flavor, obtains leaf of Moringa total extract;Leaf of Moringa is always extracted Thing passes through polycaprolactam resin, with distillation 9 retention volumes of water elution, and to eluate clarification, it is 70 v/v %'s to change concentration 4 retention volumes of ethanol elution, flow velocity is 3mL/ming, collects eluent, reclaims ethanol, obtains total flavones of Moringa oleifera leaf.
Embodiment 2
Oral effervescent tablet is made up of the component of following masses part:5 parts of leaf of Moringa total saposins, 1 part of vitamin C, sodium acid carbonate 20 Part, 20 parts of citric acid, 20 parts of calcium carbonate.
After said components are mixed, appropriate absolute ethyl alcohol is added using equal increments method, softwood processed all passes through 10 mesh Medicine is sieved, and is prepared into wet granular, and 30~40min is dried at 50~60 DEG C, then is sieved by 10 mesh medicines, and whole grain is fragrant by proper amount of edible Essence is mixed into absolute ethyl alcohol, is sprayed at particle surface, and tabletting is carried out at room temperature, produces leaf of Moringa oral effervescent tablet.
The leaf of Moringa total saposins are made through following operation:By leaf of Moringa that is fresh or drying, pass through 20 mesh medicines after pulverizing Sieve, addition 1 is calculated as by solid-to-liquid ratio g/mL:8, deionized water is added, is decocted 2 times, each 3h, merging filtrate is concentrated into relative density For 0.9~1.2mg/mL concentrated solution, 95% ethanol is added, repeatedly to add on a small quantity, does not stop stirring, until obtaining cotton-shaped Sediment, stirring without precipitation untill continuing to separate out;20h, suction filtration, filtrate decompression concentration, thickening temperature 45 are placed in 5 DEG C of refrigerators DEG C, volatilize and leaf of Moringa total saposins are obtained after solvent.
Embodiment 3
Capsule is made up of the component of following masses part:5 parts of total flavones of Moringa oleifera leaf, 5 parts of leaf of Moringa total alkaloid, beta-schardinger dextrin 1 Part, 10 parts of lactose, 20 parts of cornstarch.
After said components are mixed, appropriate absolute ethyl alcohol is added using equal increments method, softwood processed all passes through 10 mesh Medicine is sieved, and is prepared into wet granular, and 30~40min is dried at 50~60 DEG C, then is sieved by 10 mesh medicines, and whole grain loads No. 0 hard shell capsules In shell, leaf of Moringa capsule is produced.
The total flavones of Moringa oleifera leaf is made through following operation:Dry leaf of Moringa is crushed, sieved by 20 mesh medicines, by liquid material Volume ratio 5:1, after adding concentration for 40v/v% ethanol immersion 20min, refluxing extraction 3 times, each 2h, merging filtrate, decompression Concentration, 50 DEG C of thickening temperature is concentrated into medicinal extract completely without ethanol flavor, obtains leaf of Moringa total extract;Leaf of Moringa is always extracted Thing passes through polycaprolactam resin, with distillation 8 retention volumes of water elution, and to eluate clarification, it is 70 v/v %'s to change concentration 4 retention volumes of ethanol elution, flow velocity is 3mL/ming, collects eluent, reclaims ethanol, obtains total flavones of Moringa oleifera leaf.
The leaf of Moringa total alkaloid is made through following operation:Dry moringa root is crushed, sieved by 20 mesh medicines, by liquid Expect volume ratio 5:1, it is that 1wt% aqueous sulfuric acids are decocted 2 times with concentration, each 2h, merging filtrate, then the hydrogen for being 1wt% with concentration Calcium oxide adjusts pH to neutrality, is then extracted with dichloromethane, extracts 3 times repeatedly, reclaims dichloromethane, obtains leaf of Moringa Total alkaloid.
Embodiment 4
Lozenge is made up of the component of following masses part:
10 parts of leaf of Moringa total saposins, 20 parts of total flavones of Moringa oleifera leaf, 2 parts of leaf of Moringa total alkaloid, 5 parts of lactose, microcrystalline cellulose 5 Part, 5 parts of mannitol, 5 parts of yam flour.
Said components are mixed, direct powder compression, prepare leaf of Moringa lozenge.
The leaf of Moringa total saposins are made through following operation:By leaf of Moringa that is fresh or drying, pass through 20 mesh medicines after pulverizing Sieve, addition 1 is calculated as by solid-to-liquid ratio g/mL:5~10, deionized water is added, is decocted 2~3 times, 2~3h every time, merging filtrate concentration To the concentrated solution that relative density is 0.9~1.2mg/mL, 95% ethanol is added, repeatedly to add on a small quantity, does not stop stirring, directly To flocky precipitate is obtained, stirring without precipitation untill continuing to separate out;12~24h is placed in 4~6 DEG C of refrigerators, suction filtration, filtrate subtracts Pressure concentration, 40~50 DEG C of thickening temperature volatilizes and leaf of Moringa total saposins is obtained after solvent.
The total flavones of Moringa oleifera leaf is made through following operation:Dry leaf of Moringa is crushed, sieved by 20 mesh medicines, by liquid material Volume ratio 10:1, after adding concentration for 60v/v% ethanol immersion 30min, refluxing extraction 3 times, each 2h, merging filtrate, decompression Concentration, 60 DEG C of thickening temperature is concentrated into medicinal extract completely without ethanol flavor, obtains leaf of Moringa total extract;Leaf of Moringa is always extracted Thing passes through polycaprolactam resin, with distillation 10 retention volumes of water elution, and to eluate clarification, it is 70 v/v %'s to change concentration 5 retention volumes of ethanol elution, flow velocity is 3mL/ming, collects eluent, reclaims ethanol, obtains total flavones of Moringa oleifera leaf.
The leaf of Moringa total alkaloid is made through following operation:Dry moringa root is crushed, sieved by 20 mesh medicines, by liquid Expect volume ratio 5~10:1, it is that 1~5wt% aqueous sulfuric acids are decocted 2~3 times with concentration, each 2h, merging filtrate, then use concentration PH is adjusted to neutrality for 1~5wt% calcium hydroxide, is then extracted, extracted 3~5 times repeatedly with dichloromethane, reclaims two Chloromethanes, obtains leaf of Moringa total alkaloid.
The model of Moringa anti-diabetic zoopery uses chemicals revulsion, with alloxan inducing mild and moderate glycosuria Sick rat model, rat carries out gastric infusion according to 300mg/kg dosage, as a result as shown in the table.
The Moringa anti-diabetic results of animal of table 1
Test result indicates that, using alloxan diabetes rats as animal model, using antidiabetic drug melbine as control, carry out peppery The hypoglycemic activity research of wooden the different extracted parts and extract, as a result shows, total flavones of Moringa oleifera leaf, leaf of Moringa total saposins have The effect of blood glucose is reduced, as a result successive administration shows after 7 weeks, Moringa difference extract can significantly reduce blood glucose in diabetic rats, Serum MDA content is reduced simultaneously, while the vigor of serum superoxide dismutases can also be improved.

Claims (7)

1. a kind of Moringa hypoglycemic activity composition, it is characterised in that the component composition including following masses part:
0~10 part of leaf of Moringa total saposins, 0~20 part of total flavones of Moringa oleifera leaf, 0~5 part of leaf of Moringa total alkaloid, auxiliary material 20~65 Part, it is zero when wherein leaf of Moringa total saposins, total flavones of Moringa oleifera leaf are different with leaf of Moringa total alkaloid.
2. Moringa hypoglycemic activity composition according to claim 1, it is characterised in that:The auxiliary material be cornstarch, Microcrystalline cellulose, D-sorbite, fruit powder, mannitol, maltodextrin, lactose, sucrose, vitamin C, sodium acid carbonate, citric acid, carbon One or more in sour calcium.
3. Moringa hypoglycemic activity composition according to claim 1, it is characterised in that:The Moringa hypoglycemic activity group Compound also includes kudzu-vine root powder and/or yam flour, and kudzu-vine root powder and yam flour are Ultramicro-powder.
4. Moringa hypoglycemic activity composition according to claim 1, it is characterised in that:Under the leaf of Moringa total saposins warp Row operation is made:By leaf of Moringa that is fresh or drying, sieved after pulverizing by 20 mesh medicines, addition 1 is calculated as by solid-to-liquid ratio g/mL:5~ 10, deionized water is added, is decocted 2~3 times, 2~3h every time, it is 0.9~1.2mg/mL's that merging filtrate, which is concentrated into relative density, Concentrated solution, adds 95% ethanol, repeatedly to add on a small quantity, does not stop stirring, until obtaining flocky precipitate, stirring is to without heavy Form sediment untill continuing to separate out;12~24h is placed in 4~6 DEG C of refrigerators, suction filtration, filtrate decompression concentration, 40~50 DEG C of thickening temperature is waved Leaf of Moringa total saposins are obtained after dry solvent.
5. Moringa hypoglycemic activity composition according to claim 1, it is characterised in that:Under the total flavones of Moringa oleifera leaf warp Row operation is made:Dry leaf of Moringa is crushed, sieved by 20 mesh medicines, by liquid material volume ratio 5~10:1, add concentration be 40~ 60v/v% ethanol is soaked after 20~30min, refluxing extraction 2~3 times, and 2~3h, merging filtrate, are concentrated under reduced pressure every time, concentration temperature 50~60 DEG C of degree, is concentrated into medicinal extract completely without ethanol flavor, obtains leaf of Moringa total extract;By leaf of Moringa total extract by poly- Acid amides polymeric adsorbent, with distillation 8~10 retention volumes of water elution, to eluate clarification, changes the ethanol that concentration is 70 v/v % 4~5 retention volumes are eluted, flow velocity is 3mL/ming, collect eluent, reclaimed ethanol, obtain total flavones of Moringa oleifera leaf.
6. Moringa hypoglycemic activity composition according to claim 1, it is characterised in that:The leaf of Moringa total alkaloid warp Following operation is made:Dry moringa root is crushed, sieved by 20 mesh medicines, by liquid material volume ratio 5~10:1, with concentration be 1~ 5wt% aqueous sulfuric acids decoct 2~3 times, each 2h, merging filtrate, then with concentration for 1~5wt% calcium hydroxide regulation pH to Neutrality, is then extracted with dichloromethane, is extracted 3~5 times repeatedly, is reclaimed dichloromethane, is obtained leaf of Moringa total alkaloid.
7. any Moringa hypoglycemic activity composition is preparing pressed candy, oral administration effervescing in claim 1 to 6 Application in piece, lozenge, capsule.
CN201710344870.4A 2017-05-16 2017-05-16 A kind of Moringa hypoglycemic activity composition and its application Pending CN106983778A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710344870.4A CN106983778A (en) 2017-05-16 2017-05-16 A kind of Moringa hypoglycemic activity composition and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710344870.4A CN106983778A (en) 2017-05-16 2017-05-16 A kind of Moringa hypoglycemic activity composition and its application

Publications (1)

Publication Number Publication Date
CN106983778A true CN106983778A (en) 2017-07-28

Family

ID=59419799

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710344870.4A Pending CN106983778A (en) 2017-05-16 2017-05-16 A kind of Moringa hypoglycemic activity composition and its application

Country Status (1)

Country Link
CN (1) CN106983778A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107495117A (en) * 2017-09-15 2017-12-22 广东日可威食品原料有限公司 A kind of hypotensive jujube pumpkin cake and preparation method thereof

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
周玲仙: "《云南特有食物图鉴》", 31 March 2012, 云南科技出版社 *
杨玺: "《糖尿病个体化用药与调养》", 30 April 2015, 金盾出版社 *
罗晓波等: ""辣木叶的价值及其开发利用研究进展"", 《资源开发与市场》 *
董雪丽等: ""正交试验法优选辣木叶总皂苷的提取工艺"", 《现代食品科技》 *
陈瑞娇等: ""辣木叶总黄酮的提取及其降血糖作用"", 《食品与生物技术学报》 *
靳学远等: "《天然产物降血糖功能性成分研究》", 30 June 2009, 上海交通大学出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107495117A (en) * 2017-09-15 2017-12-22 广东日可威食品原料有限公司 A kind of hypotensive jujube pumpkin cake and preparation method thereof

Similar Documents

Publication Publication Date Title
Meireles et al. A review of properties, nutritional and pharmaceutical applications of Moringa oleifera: integrative approach on conventional and traditional Asian medicine
CN102273639A (en) Bird's nest fragrant product and preparation method thereof
KR101316091B1 (en) Health assistance food using dendropanax morbifera and manufacturing method thereof
CN105381306B (en) A kind of tea bag composition for alleviating alcoholic liver, brain and heart damage
WO2019029115A1 (en) Ginseng sugar for preserving health and tonifying kidney and preparation method therefor
Chowdhury et al. A review on ethnomedicinal, pharmacological, phytochemical and pharmaceutical profile of lady’s finger (Abelmoschus esculentus L.) plant
KR101380625B1 (en) Method for producing red ginseng extract comprising medicinal herbs concentrate and plant extract
CN108813501B (en) Health-preserving honey paste with functions of clearing heat, moistening lung, relieving cough, reducing phlegm, relieving asthma and regulating human body functions
CN107432911B (en) Ginseng buccal tablet for preserving health and tonifying kidney and preparation method thereof
CN104824304A (en) Selenium-enriched chocolate milk candy for old people
CN107019136A (en) A kind of solid beverage with effect of lowering blood sugar and preparation method thereof
KR100775741B1 (en) A method for the preparation of extract from Angelica gigantis radix and the composition containing the extract
CN106983778A (en) A kind of Moringa hypoglycemic activity composition and its application
CN108077512B (en) Moringa oleifera leaf blood sugar reducing tea and preparation method thereof
KR101402852B1 (en) Fermented bellflower pills and Preparation thereof
CN108434171A (en) A kind of arrowhead polysaccharide composition and preparation method thereof preventing chemical damage
CN105219602B (en) A kind of hypoglycemic root of kudzu vine yellow rice wine and preparation method thereof
CN104605429B (en) A kind of preparation method of Semen Cajani pod shell health beverage
CN102524490A (en) Beauty deodorant product and preparation method thereof
CN107950701A (en) A kind of preparation method of radix glycyrrhizae cynomorium songaricum fruit tea
CN107041445A (en) A kind of bamboo juice leaf of bamboo health protection tea for preventing and treating hypertension, hyperglycemia
CN113018398A (en) Anti-fatigue health product and preparation method thereof
CN104431670A (en) Red date and apple jam and preparation method thereof
CN108402249A (en) It is a kind of have drop weight, blood fat and liver protection effect health preserving tea and preparation method thereof
KR101192853B1 (en) Method for preparing a drink comprising extract of ginseng and taraxacum platycarpum

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170728